Skip to content

THERALINK TECHNOLOGIES, INC.: 10-Q filed 2015-10-20

What THERALINK TECHNOLOGIES, INC. reported in its quarterly report filed 2015-10-20 (fiscal Q2 2016): 18 published measures, 44 facts as tagged in accession 0001493152-15-004915.

This filing

Form
10-Q (quarterly report)
Filed
2015-10-20
Fiscal period
fiscal Q2 2016
Accession
0001493152-15-004915 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All THERALINK TECHNOLOGIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-08-314,554USD
At 2015-02-286,906USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-08-31-10,046USD
At 2015-02-28-1,044,259USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-06-01 to 2015-08-31-1,461,580USD92
2015-03-01 to 2015-08-31-1,656,595USD184
2014-06-01 to 2014-08-31983USD92
2014-03-01 to 2014-08-31-92,093USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2015-03-01 to 2015-08-31-39,255USD184
2014-03-01 to 2014-08-31-149,402USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-06-01 to 2014-08-318USD92
2014-03-01 to 2014-08-3174USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2015-03-01 to 2015-08-3137,000USD184
2014-03-01 to 2014-08-31175,000USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-08-31-5,404,683USD
At 2015-02-28-3,748,088USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-03-01 to 2015-08-31159,415USD184
2014-03-01 to 2014-08-310USD184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-06-01 to 2015-08-31-173,653USD92
2015-03-01 to 2015-08-31-196,029USD184
2014-06-01 to 2014-08-31-98,052USD92
2014-03-01 to 2014-08-31-182,311USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-08-314,554USD
At 2015-02-286,906USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-03-01 to 2015-08-311,284,130USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-08-3114,600USD
At 2015-02-281,051,165USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-06-01 to 2015-08-31173,653USD92
2015-03-01 to 2015-08-31196,029USD184
2014-06-01 to 2014-08-3198,060USD92
2014-03-01 to 2014-08-31182,385USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-08-314,493,372shares
At 2015-02-28451,639shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-08-315,394,187USD
At 2015-02-282,703,784USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2015-02-2897USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-06-01 to 2015-08-315,120USD92
2015-03-01 to 2015-08-3112,164USD184
2014-06-01 to 2014-08-3152,408USD92
2014-03-01 to 2014-08-3184,355USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-06-01 to 2015-08-31-1,287,927USD92
2015-03-01 to 2015-08-31-1,460,566USD184
2014-06-01 to 2014-08-31-10,414USD92
2014-03-01 to 2014-08-31-19,231USD184

Inspect the source

Entity
THERALINK TECHNOLOGIES, INC. / CIK 0001362703
Captured
SEC response SHA-256
8ea68b29937a9dc79f3f437bfa115ba2d25bc4aa61d4ac37350bf0c10a93ef12

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001362703.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))